Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

MacroGenics Company Profile (NASDAQ:MGNX)

Consensus Ratings for MacroGenics (NASDAQ:MGNX) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $50.50 (150.00% upside)

Analysts' Ratings History for MacroGenics (NASDAQ:MGNX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/10/2014OppenheimerInitiated CoverageOutperform$48.00ViewTweet This Rating  Share This Rating on StockTwits
6/19/2014Roth CapitalBoost Price Target$28.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
6/9/2014Roth CapitalInitiated CoverageBuy$28.00ViewTweet This Rating  Share This Rating on StockTwits
3/21/2014Stifel NicolausBoost Price Target$51.00 -> $53.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2014Stifel NicolausBoost Price TargetBuy$35.00 -> $51.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2014Leerink SwannBoost Price TargetOutperform$34.00 -> $52.00ViewTweet This Rating  Share This Rating on StockTwits
2/18/2014Bank of AmericaUpgradeNeutral -> Buy$30.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
12/3/2013WedbushInitiated CoverageOutperform$70.00ViewTweet This Rating  Share This Rating on StockTwits
11/4/2013Lazard Capital MarketsInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
11/4/2013Stifel NicolausInitiated CoverageBuy$35.00ViewTweet This Rating  Share This Rating on StockTwits
11/4/2013Leerink SwannInitiated CoverageOutperform$34.00ViewTweet This Rating  Share This Rating on StockTwits
11/4/2013Bank of AmericaInitiated CoverageNeutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2012 forward)